chrX-111736757-A-G
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001099922.3(ALG13):āc.2573A>Gā(p.Asn858Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000265 in 1,209,200 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N858D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001099922.3 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 36Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111994Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.000124 AC: 22AN: 177333 AF XY: 0.0000460 show subpopulations
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1097206Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 5AN XY: 362742 show subpopulations
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111994Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34158 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.N858S variant (also known as c.2573A>G), located in coding exon 23 of the ALG13 gene, results from an A to G substitution at nucleotide position 2573. The asparagine at codon 858 is replaced by serine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Developmental and epileptic encephalopathy, 36 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at